Perioperative management of ambulatory surgical patients with diabetes mellitus

Current Opinion in Anaesthesiology

Volumn 22, Issue 6, 2009, Pages 718-724

  Vann, Mary Ann ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Ambulatory anesthesia; Ambulatory surgery; Diabetes; Hyperglycemia; Perioperative insulin

Indexed keywords

DEXAMETHASONE; EXENDIN 4; GLUCOSE; GLULISINE; HEMOGLOBIN A1C; INCRETIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; NOVALOG; ORAL ANTIDIABETIC AGENT; PRAMLINITIDE; PROTAMINE; SITAGLIPTIN; SULFONYLUREA; SYMLIM; UNCLASSIFIED DRUG;

AMBULATORY SURGERY; ANESTHESIST; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG WITHDRAWAL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MORNING DOSAGE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH EMPTYING; VOMITING;

AMBULATORY SURGICAL PROCEDURES; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTRAOPERATIVE CARE; PERIOPERATIVE CARE;

EID: 70449461204     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283310f51     Document Type: Review

References (35)

1. American Association of Clinical Endocrinologists and American Diabetes Association. Consensus statement on inpatient glycemic control. Diabetes Care 2009; 32:1119-1131.
2. Maynard G, O'Malley CW, Kirsh SR. Perioperative care of the geriatric patient with diabetes or hyperglycemia. Clin Geriatr Med 2008; 24:649-665.
3. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008; 31 (Suppl 1):s12-s54.
4. Lipshutz AKM, Gropper MA. Perioperative glycemic control. Anesthesiology 2009; 110:408-421.
5. Bailey CJ, Day C. Fixed-dose single tablet antidiabetic combinations. Diabetes Obesity Metabolism 2009; 11:527-533.
6. Jacober SJ, Sowers JR. An update on perioperative management of diabetes. Arch Intern Med 1999; 159:2405-2411.
7. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
8. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effect of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559.
9. The Veterans Affairs Diabetes Trial. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360:129-139.
10. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE and VA diabetes trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 2009; 119:351-357.
11. Halkos ME, Puskas JD, Lattoug OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary bypass surgery. J Thorac Cardiovasc Surg 2008; 136:631-640.
12. Phillip M, Danne T, Battelino T, et al. Use of insulin pump therapy in the pediatric age-group. (Consensus statement from the European Society for Paediatric Endrocrinology et al. . . . endorsed by the American Diabetes Association and the European Association for the Study of Diabetes). Diabetes Care 2007; 30:1653-1662.
13. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and mortality in critically ill patients. Anesthesiology 2006; 105:244-252.
14. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295:1681-1687.
15. Griesdale DEG, deSouza RJ, vanDam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821-827.
16. Subramanian B, Panzica PJ, Novack V, et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery. Anesthesiology 2009; 110:970-977.
17. Cefalu WT. Glycemic targets and cardiovascular disease [editorial]. N Engl J Med 2008; 358:2633-2635.
18. Hans P, Vanthuyne A, Dewandre PY, et al. Blood glucose concentration profile after 10mg dexamethasone in nondiabetic and type 2 diabetic patients undergoing abdominal surgery. Br J Anaesth 2006; 97:164-170. (Pubitemid 44295700)
19. Schmeltz LR, Henske J, DeSantis AJ, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007; 30:823-828.
20. Gandhi GY, Murad MH, Flynn DN, et al. Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials. Mayo Clin Proc 2008; 83:418-430.
21. Ferrari LR. New insulin analogues and insulin delivery devices for the perioperative management of diabetic patients. Curr Opin Anaesthesiol 2008; 21:401-405.
22. Rhodes ET, Ferrari LR, Wolfsdorf JI. Perioperative management of pediatric surgical patients with diabetes mellitus. Anesth Analg 2005; 101:986-989.
23. Inzucchi SE. Management of hyperglycemia in the hospital setting. N Engl J Med 2006; 355:1903-1911.
24. Albacker T, Carvalho G, Schricker T, Lachapelle K. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 2008; 86:20-28.
25. Lauruschkat AH, Arnrich B, Albert AA, et al. Diabetes mellitus as a risk factor for pulmonary complications after coronary bypass surgery. J Thorac Cardiovasc Surg 2008; 135:1047-1053.
26. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26:1902-1912.
27. Nathan DM, Holman RR, Buse JB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009; 32:193-203.
28. Chen D, Lee SL, Peterfreund RA. New therapeutic agents for diabetes mellitus: implications for anesthetic management. Anesth Analg 2009; 108:1803-1810.
29. Betts P, Brink SJ, Swift PGF, et al. Management of children with diabetes requiring surgery. Pediatr Diabetes 2007; 8:242-247.
30. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin Lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004; 117:291-296.
31. Ahmed Z, Lockhart CH, Weiner M, Klingensmith G. Advances in diabetic management: implications for anesthesia. Anesth Analg 2005; 100:666-669.
32. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
33. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300:933-944.
34. Bilotta F, Caramia R, Paoloni FP, et al. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009; 110:611-619.
35. Rohlgin CL, Wiedmeyer HM, Little RR, et al. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25:275-278.